Clinical Trial Update: Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating predictors of response to DMARD therapy in rheumatoid arthritis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: University of Nebraska | Conditions: Rheumatoid Arthritis | Phase 3 | Status: RECRUITING